Home

Nantahala Capital Management reported a 6.9% stake in Keros Therapeutics KROS · 1,360,419 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
6.9%
Last report
First report
Shares held
1,360,419 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/03/31
Filed
26/05/15

First 5%+ report · 6.9% stake

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Nantahala Capital Management's other 5% stake reports